glp-1 hers Full Range of FDA-Approved GLP-1s Available on Hims & Hims & Hers Launches New

For food and beverage companies, understanding how their use might evolve will be critical to staying relevant, from reformulating products to meeting new nutritional needs

Glenn Lyle in Raleigh, NC.

Check your GLP-1 receptor gene variants linked to weight loss response

Pharmacovigilance analyses identified disproportionate reporting signals for dyspnoea and asthma-like events, particularly with exenatide, using the reporting odds ratio (ROR 2.14, 95% CI 1.882.43

Learn about eligibility, deadlines, and how to file a claim.

Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control